Pavel I. Nedvetsky
Muenster, NW 48149, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
APOL1 plasma membrane pools resist rapid protein degradation.
Journal: Scientific reports
Published: November 17, 2025
PATJ deficiency leads to cystic kidney disease and related ciliopathies.
Journal: HGG advances
Published: April 22, 2025
Modulating the Activity of the Human Organic Cation Transporter 2 Emerges as a Potential Strategy to Mitigate Unwanted Toxicities Associated with Cisplatin Chemotherapy.
Journal: International journal of molecular sciences
Published: February 15, 2024
PATJ inhibits histone deacetylase 7 to control tight junction formation and cell polarity.
Journal: Cellular and molecular life sciences : CMLS
Published: June 06, 2023
PALS1 is a key regulator of the lateral distribution of tight junction proteins in renal epithelial cells.
Journal: Journal of cell science
Published: May 03, 2023
A SEC61A1 variant is associated with autosomal dominant polycystic liver disease.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 21, 2022
Vascular and Liver Homeostasis in Juvenile Mice Require Endothelial Cyclic AMP-Dependent Protein Kinase A.
Journal: International journal of molecular sciences
Published: August 16, 2022
Activation of Hippo Pathway Damages Slit Diaphragm by Deprivation of Ajuba Proteins.
Journal: Journal of the American Society of Nephrology : JASN
Published: July 22, 2022
Pals1 functions in redundancy with SMAP1 to inhibit Arf6 in order to prevent Rac1-dependent colorectal cancer cell migration and invasion.
Journal: Cancer gene therapy
Published: March 14, 2022
Properties of Transport Mediated by the Human Organic Cation Transporter 2 Studied in a Polarized Three-Dimensional Epithelial Cell Culture Model.
Journal: International journal of molecular sciences
Published: August 18, 2021
Last Updated: 09/26/2026